Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once vs twice daily prednisolone and effects on glycemia in ANCA vasculitis
2019-002068-29Phase 4Active
- Sponsor
- Medical University of Graz
- Start
- Sep 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of prednisolone in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) (2 arms), sponsored by Medical University of Graz. Primary endpoint: Mean percentage of time in glycemic target range. Started Sep 2019; status: active.
02
Drugs
prednisolone
03
Conditions
anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV)
Beyond the preview
Go deeper on 2019-002068-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002068-29.